Study conducted at US sites evaluates LumeeTM in peripheral artery disease (PAD) patientsBERKELEY, Calif, Jan. 29, 2026 (GLOBE NEWSWIRE) -- ...
Through this collaboration, Glucotrack will leverage next-generation artificial intelligence and machine learning-based analytics to evaluate clinical study data from its Continuous Blood Glucose ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果